Kathryn Klein
Clinical Trial Shows Rare Skin Cancer Responding to Immunotherapy
A clinical trial recently reported in the Journal of Clinical Oncology showed that several people with advanced Merkel cell carcinoma, a rare form of skin cancer,...
Study Says Women at Risk Should Screen Earlier for Breast Cancer
A study sponsored by the charity Breast Cancer Now revealed that women with a family history of breast cancer should start annual screenings in...
Healing Your Body with The Gerson Therapy
Back in the 1920's, a young German doctor named Max Gerson discovered a method that cured him from migraine headaches. The method was so...
5 Reasons Why We Needed “Right to Try” Law
The federal "Right to Try" law makes it possible for terminally ill patients to access investigational treatments that are not yet approved by the...
“Right to Try” Namesake Begins Treatment Under Law He Fought to...
One year ago during President Trump’s 2018 State of the Union Address, Matt Bellina watched eagerly from the gallery as the president encouraged Congress...
Trump’s State of the Union Highlights Significant “Right to Try” Law
Among his many references to health-related concerns in the 2019 State of the Union address, President Trump stressed the significance of his federal “Right...
Here’s What You Should Know About Immunotherapy
Immunotherapy has been changing the way the world looks at cancer. Previously, we had only three options when it came to destroying cancer: cut,...
Brain Cancer Patient Receives Treatment Under “Right to Try” Law
A California patient with an aggressive form of brain cancer called glioblastoma has begun investigational treatments under the "Right to Try" law passed in...
What Does the Right to Try Law Really Mean for Terminally...
Last May, President Trump passed a federal law that says terminally ill patients have the right to use experimental treatments that haven’t yet been...
Study Reveals How Immunotherapies May Treat Brain Tumors
A new study published in Nature Medicine revealed that neurofibromatosis type 1 (NF1) patients who have slow-growing brain tumors may have promising results with immunotherapy...
